“We have a few scars. It has not been very fun for us these past two years.” Dr. Philippe Archinard, chairman and CEO of Transgene SA, does not deny the company has had its troubles. However, in an interview with Scrip, he outlined why he believes French biotech company’s time may finally be coming.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?